Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry - Top-Institutions - MDSpire

Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry

  • By

  • Marisa Iborra

  • Berta Caballol

  • Alejandro Garrido

  • José María Huguet

  • Francisco Mesonero

  • Ángel Ponferrada

  • Lara Arias García

  • Marta Maia Boscá Watts

  • Samuel J Fernández Prada

  • Eduard Brunet Mas

  • Ana Gutiérrez Casbas

  • Elena Cerrillo

  • Ingrid Ordás

  • Lucía Ruiz

  • Irene García de la Filia

  • Jaime Escobar Ortiz

  • Beatriz Sicilia

  • Elena Ricart

  • Eugeni Domènech

  • Pilar Nos

  • August 22, 2024

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mount Sinai Hospital
    Mount Sinai Hospital

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Clinical Pharmacology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Pharmacology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Immunology

  • #4

    Hospital Clinic Barcelona
    Hospital Clinic Barcelona

    Barcelona, Catalonia

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Clinical Pharmacology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Clinical Research

Original Source(s)

Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry

  • by Marisa Iborra, Berta Caballol, Alejandro Garrido, José María Huguet, Francisco Mesonero, Ángel Ponferrada, Lara Arias García, Marta Maia Boscá Watts, Samuel J Fernández Prada, Eduard Brunet Mas, Ana Gutiérrez Casbas, Elena Cerrillo, Ingrid Ordás, Lucía Ruiz, Irene García de la Filia, Jaime Escobar Ortiz, Beatriz Sicilia, Elena Ricart, Eugeni Domènech, Pilar Nos

  • August 22, 2024

Related Content

Mortality trends from colorectal pathologies in the United States (1999–2020): a retrospective cohort study using CDC WONDER

Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists

Strategies for Organ Regeneration Using Cell Therapy